0000899243-21-000682.txt : 20210106 0000899243-21-000682.hdr.sgml : 20210106 20210106160513 ACCESSION NUMBER: 0000899243-21-000682 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gordon Gary B. CENTRAL INDEX KEY: 0001811354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 21510500 MAIL ADDRESS: STREET 1: C/O AYALA PHARMACEUTICALS, INC. STREET 2: OPPENHEIMER 4 CITY: REHOVOT STATE: L3 ZIP: 7670104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001811354 Gordon Gary B. OPPENHEIMER 4 REHOVOT L3 7670104 ISRAEL 0 1 0 0 Chief Medical Officer Common Stock 2021-01-04 4 A 0 8520 0.00 A 8520 D Stock Option 11.26 2021-01-04 4 A 0 19170 0.00 A 2031-01-03 Common Stock 19170 19170 D This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 4, 2025. /s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Gary B. Gordon 2021-01-06